Whitehawk Therapeutics (WHWK) EBITDA Margin (2018 - 2025)
Whitehawk Therapeutics' (WHWK) quarterly EBITDA Margin came in at 212.99% in Q1 2025, up 15152.0% year-on-year from N/an in Q1 2024, and up 18.63% on a QoQ basis from 261.76% in Q4 2024.
Whitehawk Therapeutics (WHWK) EBITDA Margin (2018 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 7 years of EBITDA Margin data on file, last reported at 212.99% in Q1 2025.
- On a quarterly basis, EBITDA Margin rose 15152.0% year-over-year to 212.99% in Q1 2025; TTM through Dec 2025 was 1601.12%, a 134150.0% decrease from a year earlier, with the FY2025 full-year figure at 1601.12%, down 134150.0% from the prior year.
- EBITDA Margin for Q1 2025 stood at 212.99%, up from 261.76% in the prior quarter.
- Over the last five years, EBITDA Margin for WHWK reached as high as 113.89% in Q4 2021 and fell as low as 3405.83% in Q1 2021.
- Historically, EBITDA Margin has averaged 517.45% across 5 years, with a median of 296.0% in 2022.
- On a YoY basis, EBITDA Margin climbed as much as 280705 bps in 2022 and fell as far as 18211 bps in 2022.
- Year by year, EBITDA Margin stood at 113.89% in 2021, then tumbled by 160 bps to 296.0% in 2022, then rose by 5 bps to 280.02% in 2023, then gained by 7 bps to 261.76% in 2024, then rose by 19 bps to 212.99% in 2025.
- Per Business Quant data, the three most recent EBITDA Margin figures were 212.99% in Q1 2025, 261.76% in Q4 2024, and 185.98% in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -212.99% |
| Dec 31, 2024 | -261.76% |
| Sep 30, 2024 | -185.98% |
| Jun 30, 2024 | -252.21% |
| Mar 31, 2024 | -364.51% |
| Dec 31, 2023 | -280.02% |
| Sep 30, 2023 | -299.53% |
| Jun 30, 2023 | -315.14% |
| Mar 31, 2023 | -286.77% |
| Dec 31, 2022 | -296.00% |
| Sep 30, 2022 | -354.20% |
| Jun 30, 2022 | -534.19% |
| Mar 31, 2022 | -598.79% |
| Dec 31, 2021 | -113.89% |
| Mar 31, 2021 | -3,405.83% |
| Dec 31, 2020 | 60.03% |
| Sep 30, 2020 | -1,152.81% |
| Jun 30, 2020 | 61.71% |
| Dec 31, 2018 | -413,534.42% |
| Sep 30, 2018 | 59.49% |